Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 13/20 | 0.36 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL142273 | 0.91 | APP (0.34) | APPSQORARKDM4ERECQL | |
| SCHEMBL142121 | 0.87 | RARB (0.44) | APPKDM4E | |
| SCHEMBL20546963 | 0.86 | TRPV4 (0.42) | SQORARKDM4ETRPV4MGAT2 | |
| SCHEMBL29225925 | 0.85 | TRPV4 (0.37) | KDM4ETRPV4MGAT2 | |
| SCHEMBL13049296 | 0.84 | SQOR (0.39) | SQORARKDM4ERECQLTRPV4 | |
| SCHEMBL141714 | 0.81 | RARB (0.44) | APPSQORARKDM4ERECQL | |
| SCHEMBL30933448 | 0.81 | MAPT (0.36) | KDM4ETRPV4MGAT2 | |
| SCHEMBL30933449 | 0.81 | MAPT (0.36) | KDM4ETRPV4MGAT2 | |
| SCHEMBL14964488 | 0.80 | RARB (0.42) | APPKDM4EMGAT2 | |
| SCHEMBL14964489 | 0.79 | KDM4E (0.42) | APPKDM4EMGAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130341573-A1 | PHOTOREFRACTIVE COMPOSITION COMPRISING ELECTROLYTES IN A PHOTOREFRACTIVE LAYER AND METHOD OF MAKING THEREOF | NITTO DENKO CORPORATION (JP) | 2013-12-26 | — | — | US | disclosed |
| US-20130341574-A1 | PHOTOREFRACTIVE COMPOSITION AND DEVICE COMPRISING THE COMPOSITION | NITTO DENKO CORPORATION (JP) | 2013-12-26 | — | — | US | disclosed |
| WO-2013075050-A1 | PHOTOREFRACTIVE DEVICE CONTAINING CARBON NANOTUBE-DOPED POLYMER LAYERS AND ITS MANUFACTURING METHOD | NITTO DENKO CORPORATION (JP) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013075050-A1 | PHOTOREFRACTIVE DEVICE CONTAINING CARBON NANOTUBE-DOPED POLYMER LAYERS AND ITS MANUFACTURING METHOD | NITTO DENKO CORPORATION (JP) | 2013-05-23 | — | — | WO | disclosed |
| US-8420235-B2 | Emissive diaryl acetylenes | NITTO DENKO CORPORATION (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8420235-B2 | Emissive diaryl acetylenes | NITTO DENKO CORPORATION (JP) | 2013-04-16 | — | — | US | disclosed |
| WO-2012116071-A1 | PHOTOREFRACTIVE COMPOSITION COMPRISING ELECTROLYTES IN A PHOTOREFRACTIVE LAYER AND METHOD OF MAKING THEREOF | NITTO DENKO CORPORATION (JP) | 2012-08-30 | — | — | WO | disclosed |
| WO-2012116105-A1 | A PHOTOREFRACTIVE COMPOSITION AND DEVICE COMPRISING THE COMPOSITION | NITTO DENKO CORPORATION (JP) | 2012-08-30 | — | — | WO | disclosed |
| US-20120058418-A1 | THREE-DIMENSIONAL HOLOGRAPHIC DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20120058418-A1 | THREE-DIMENSIONAL HOLOGRAPHIC DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2012-03-08 | — | — | US | disclosed |
| WO-2010141754-A1 | EMISSIVE DIARYL ACETYLENES | NITTO DENKO CORPORATION (JP) | 2010-12-09 | — | — | WO | disclosed |
| US-20100308716-A1 | EMISSIVE DIARYL ACETYLENES | NITTO DENKO CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| US-20100308716-A1 | EMISSIVE DIARYL ACETYLENES | NITTO DENKO CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100308716-A1 | EMISSIVE DIARYL ACETYLENES | B3GNT2, GSTO1, NAT1 | APP 2230/4885SQOR 148/4885AR 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.